Literature DB >> 20733092

Trends in time to confirmation and recognition of new-onset hypertension, 2002-2006.

Joe V Selby1, Janelle Lee, Bix E Swain, Heather M Tavel, P Michael Ho, Karen L Margolis, Patrick J O'Connor, Lawrence Fine, Julie A Schmittdiel, David J Magid.   

Abstract

Achieving full benefits of blood pressure control in populations requires prompt recognition of previously undetected hypertension. In 2003, the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure provided definitions of hypertension and recommended that single elevated readings be confirmed within 1 to 2 months. We sought to determine whether the time required to confirm and recognize (ie, diagnose and/or treat) new-onset hypertension decreased from 2002 to 2006 for adult members of 2 large integrated healthcare delivery systems, Kaiser Permanente Northern California and Colorado. Using electronically stored office blood pressure readings, physician diagnoses, and pharmacy prescriptions, we identified 200 587 patients with new-onset hypertension (2002-2006) marked by 2 consecutive elevated blood pressure readings in previously undiagnosed, untreated members. Mean confirmation intervals (time from the first to second consecutive elevated reading) declined steadily from 103 to 89 days during this period. For persons recognized within 12 months after confirmation, the mean interval to recognition declined from 78 to 61 days. However, only 33% of individuals were recognized within 12 months. One third were never recognized during observed follow-up. For these patients, most subsequent blood pressure recordings were not elevated. Higher initial blood pressure levels, history of previous cardiovascular disease, and older age were associated with shorter times to recognition. Times to confirmation and recognition of new-onset hypertension have become shorter in recent years, especially for patients with higher cardiovascular disease risk. Variability in office-based blood pressure readings suggests that further improvements in recognition and treatment may be achieved with more specific automated approaches to identifying hypertension.

Entities:  

Mesh:

Year:  2010        PMID: 20733092      PMCID: PMC2975575          DOI: 10.1161/HYPERTENSIONAHA.110.153528

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  26 in total

1.  Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators.

Authors:  J A Staessen; L Thijs; R Fagard; E T O'Brien; D Clement; P W de Leeuw; G Mancia; C Nachev; P Palatini; G Parati; J Tuomilehto; J Webster
Journal:  JAMA       Date:  1999-08-11       Impact factor: 56.272

2.  Inadequate management of blood pressure in a hypertensive population.

Authors:  D R Berlowitz; A S Ash; E C Hickey; R H Friedman; M Glickman; B Kader; M A Moskowitz
Journal:  N Engl J Med       Date:  1998-12-31       Impact factor: 91.245

3.  Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Authors: 
Journal:  JAMA       Date:  2002-12-18       Impact factor: 56.272

4.  Aim, design and methods of the 'reasons for not intensifying antihypertensive treatment' (RIAT): an international registry in essential hypertension.

Authors:  P Ferrari; S-K Kim; C J Wu; N V Pham; F Ageev; L D Hermosillo; R Esper
Journal:  J Hum Hypertens       Date:  2006-01       Impact factor: 3.012

5.  The implications of blood pressure variability for clinical and screening purposes.

Authors:  B Rosner; B F Polk
Journal:  J Chronic Dis       Date:  1979

6.  Physician-related barriers to the effective management of uncontrolled hypertension.

Authors:  Susan A Oliveria; Pablo Lapuerta; Bruce D McCarthy; Gilbert J L'Italien; Dan R Berlowitz; Steven M Asch
Journal:  Arch Intern Med       Date:  2002-02-25

7.  Morehouse Community Physicians Network (CPN) hypertension registry: patterns of care and opportunities for targeted medical education.

Authors:  Priscilla Igho-Pemu; Alexander Quarshie; Adefisayo Oduwole; Rigobert Lapu-Bula; Robert Mayberry; Chamberlain Obialo; Gary H Gibbons; Elizabeth Ofili
Journal:  Ethn Dis       Date:  2005       Impact factor: 1.847

8.  Therapy modifications in response to poorly controlled hypertension, dyslipidemia, and diabetes mellitus.

Authors:  Nicolas Rodondi; Tiffany Peng; Andrew J Karter; Douglas C Bauer; Eric Vittinghoff; Simon Tang; Daniel Pettitt; Eve A Kerr; Joe V Selby
Journal:  Ann Intern Med       Date:  2006-04-04       Impact factor: 25.391

9.  High rates of co-occurrence of hypertension, elevated low-density lipoprotein cholesterol, and diabetes mellitus in a large managed care population.

Authors:  Joe V Selby; Tiffany Peng; Andrew J Karter; Mark Alexander; Stephen Sidney; Jean Lian; Amy Arnold; Dan Pettitt
Journal:  Am J Manag Care       Date:  2004-02       Impact factor: 2.229

10.  Quality of care for hypertension in the United States.

Authors:  Steven M Asch; Elizabeth A McGlynn; Liisa Hiatt; John Adams; Jennifer Hicks; Alison DeCristofaro; Roland Chen; Pablo LaPuerta; Eve A Kerr
Journal:  BMC Cardiovasc Disord       Date:  2005-01-07       Impact factor: 2.298

View more
  15 in total

1.  Incidence and prognosis of resistant hypertension in hypertensive patients.

Authors:  Stacie L Daugherty; J David Powers; David J Magid; Heather M Tavel; Frederick A Masoudi; Karen L Margolis; Patrick J O'Connor; Joe V Selby; P Michael Ho
Journal:  Circulation       Date:  2012-02-29       Impact factor: 29.690

2.  The association between medication adherence and treatment intensification with blood pressure control in resistant hypertension.

Authors:  Stacie L Daugherty; J David Powers; David J Magid; Frederick A Masoudi; Karen L Margolis; Patrick J O'Connor; Julie A Schmittdiel; P Michael Ho
Journal:  Hypertension       Date:  2012-06-25       Impact factor: 10.190

3.  Missed opportunities in cardiovascular disease prevention?: low rates of hypertension recognition for women at medicine and obstetrics-gynecology clinics.

Authors:  Julie Schmittdiel; Joe V Selby; Bix Swain; Stacie L Daugherty; Thomas K Leong; Michael Ho; Karen L Margolis; Patrick O'Connor; David J Magid; Kirsten Bibbins-Domingo
Journal:  Hypertension       Date:  2011-02-21       Impact factor: 10.190

4.  Health system factors and antihypertensive adherence in a racially and ethnically diverse cohort of new users.

Authors:  Alyce S Adams; Connie Uratsu; Wendy Dyer; David Magid; Patrick O'Connor; Arne Beck; Melissa Butler; P Michael Ho; Julie A Schmittdiel
Journal:  JAMA Intern Med       Date:  2013-01-14       Impact factor: 21.873

5.  An investigation of associations between clinicians' ethnic or racial bias and hypertension treatment, medication adherence and blood pressure control.

Authors:  Irene V Blair; John F Steiner; Rebecca Hanratty; David W Price; Diane L Fairclough; Stacie L Daugherty; Michael Bronsert; David J Magid; Edward P Havranek
Journal:  J Gen Intern Med       Date:  2014-02-19       Impact factor: 5.128

6.  Comparative effectiveness of 2 β-blockers in hypertensive patients.

Authors:  Emily D Parker; Karen L Margolis; Nicole K Trower; David J Magid; Heather M Tavel; Susan M Shetterly; P Michael Ho; Bix E Swain; Patrick J O'Connor
Journal:  Arch Intern Med       Date:  2012-10-08

7.  Longitudinal study of implantable cardioverter-defibrillators: methods and clinical characteristics of patients receiving implantable cardioverter-defibrillators for primary prevention in contemporary practice.

Authors:  Frederick A Masoudi; Alan S Go; David J Magid; Andrea E Cassidy-Bushrow; Jonathan M Doris; Frances Fiocchi; Romel Garcia-Montilla; Karen A Glenn; Robert J Goldberg; Nigel Gupta; Jerry H Gurwitz; Stephen C Hammill; John J Hayes; Nathaniel Jackson; Alan Kadish; Michael Lauer; Aaron W Miller; Deborah Multerer; Pamela N Peterson; Liza M Reifler; Kristi Reynolds; Jane S Saczynski; Claudio Schuger; Param P Sharma; David H Smith; Mary Suits; Sue Hee Sung; Paul D Varosy; Humberto J Vidaillet; Robert T Greenlee
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2012-11

8.  Identifying hypertension in pregnancy using electronic medical records: The importance of blood pressure values.

Authors:  Lu Chen; Susan M Shortreed; Thomas Easterling; T Craig Cheetham; Kristi Reynolds; Lyndsay A Avalos; Aruna Kamineni; Victoria Holt; Romain Neugebauer; Mary Akosile; Nerissa Nance; Zoe Bider-Canfield; Rod L Walker; Sylvia E Badon; Sascha Dublin
Journal:  Pregnancy Hypertens       Date:  2020-01-03       Impact factor: 2.899

9.  Sex differences in cardiovascular outcomes in patients with incident hypertension.

Authors:  Stacie L Daugherty; Frederick A Masoudi; Chan Zeng; P Michael Ho; Karen L Margolis; Patrick J O'Connor; Alan S Go; David J Magid
Journal:  J Hypertens       Date:  2013-02       Impact factor: 4.844

10.  Simultaneous control of diabetes mellitus, hypertension, and hyperlipidemia in 2 health systems.

Authors:  Emily B Schroeder; Rebecca Hanratty; Brenda L Beaty; Elizabeth A Bayliss; Edward P Havranek; John F Steiner
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2012-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.